ハイコンテントスクリーニング (HCS) / イメージング：技術と世界市場

世界のハイコンテントスクリーニング (HCS) / イメージング市場は、2018年の9億1,500万米ドルから2023年までに17億米ドルへ達すると予測され、この間は13.1%のCAGR (年間複合成長率) が見込まれています。

当レポートでは、世界のハイコンテントスクリーニング (HCS) / イメージング市場について調査し、市場および技術の概要、市場動向とデータ実績・予測、技術進歩の詳細分析、および主要企業のプロファイルなどを提供しています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場・技術背景

• 顕微鏡・イメージング技術の概要
• 技術進歩
• プロセス概要
• 市場ダイナミクス

第4章 市場分析：コンポーネント別

• 装置またはプラットフォーム
• 消耗品 (試薬・キット)
• ソフトウェア・分析
• サービス

第5章　市場分析：エンドユーザー別

• 大学
• ラボ・病理センター
• 企業 (バイオテクノロジー、医薬品、およびCRO)

第6章　市場分析：用途別

• 分子診断
• 腫瘍
• 創薬
• 毒性研究
• 神経科学
• 化合物プロファイリング

第7章　市場分析：地域別

• 北米
• 欧州
• MEA (中東・アフリカ)
• アジア太平洋
• その他

第8章　特許レビュー

第9章　産業構造

• メーカー/サプライヤー
  • Thermo Fisher Scientific
  • GE Healthcare
  • オリンパス
  • Molecular Devices
  • PerkinElmer, Inc.

第10章　企業プロファイル

• ALBANY MOLECULAR RESEARCH, INC. (AMRI)
• AURELIA BIOSCIENCE LTD.
• AXXAM SPA
• BECTON, DICKINSON AND CO.
• BIOTEK INSTRUMENTS, INC.
• CHARLES RIVER
• CORNING, INC.
• CREATIVE BIOLABS
• CURIOX BIOSYSTEMS, INC.
• CYTOO SA
• DANAHER CORP.
• DE NOVO SOFTWARE
• DEFINIENS AG
• DISCOVERX CORP.
• ESSEN BIOSCIENCE
• EVOTEC AG
• FLUXION BIOSCIENCES
• GE HEALTHCARE
• GENEDATA AG
• HUDSON ROBOTICS, INC.
• INSTRUMENT SYSTEMS
• INTELLICYT CORP.
• LUMENCOR, INC.
• MERCK MILLIPORE
• MOLECULAR DEVICES
• NEMAMETRIX, INC.
• NIKON INSTRUMENTS, INC.
• オリンパス
• PERKINELMER, INC.
• PHENOVISTA BIOSCIENCES LLC
• PLATYPUS TECHNOLOGIES
• SYSMEX CORP.
• TECAN GROUP LTD.
• THERMO FISHER SCIENTIFIC, INC.
• THORLABS, INC.
• VALA SCIENCES, INC.
• 横河電機
• ZEISS GROUP

List of Tables

• Summary Table: Global Market for High Content Screening/Imaging, by Component, Through 2023
  • Table 1: Microscopes Used in HCS/I
  • Table 2: HTS Detection Methods
  • Table 3: HTS Product Portfolios
  • Table 4: Comparison of Cellomics with Other Omics Techniques
  • Table 5: Comparison of HCS Microscopes
  • Table 6: Global Market for HCS/I, by Component, Through 2023
  • Table 7: Global Market for HCS/I, by Instrument/Platform, Through 2023
  • Table 8: Global Market for Instruments/Platforms, by Region, Through 2023
  • Table 9: HCS Platforms, by Thermo Fisher Scientific
  • Table 10: Cytometers
  • Table 11: Microplate Readers Available in the Market and Their Manufacturers
  • Table 12: Fluorescent Dyes Used for the Sensor Array
  • Table 13: Automated Liquid Handling Modules
  • Table 14: Global Market for Consumables, by Region, Through 2023
  • Table 15: Specification of HCS Live/Dead Green Kit
  • Table 16: Global Market for Software and Analytics, by Region, Through 2023
  • Table 17: Global Market for Services, by Region, Through 2023
  • Table 18: Global Market for HCS/I, by End User, Through 2023
  • Table 19: Global Market for HCS/I in Academics, by Region, Through 2023
  • Table 20: Institutes with HCS Facilities
  • Table 21: Global Market for HCS/I in Laboratories and Pathology Centers, by Region, Through 2023
  • Table 22: Global Market for HCS/I Used by Companies, by Region, Through 2023
  • Table 23: Global Market for HCS/I, by Application, Through 2023
  • Table 24: Global Market for HCS/I, by Region, Through 2023
  • Table 25: Global Market for HCS/I in Molecular Diagnostics, by Region, Through 2023
  • Table 26: Global Market for HCS/I in Oncology, by Region, Through 2023
  • Table 27: Global Market for HCS/I in Drug Discovery, by Region, Through 2023
  • Table 28: Evotec Products in Development for Cancer in Various Stages of Research
  • Table 29: Global Market for HCS/I in Toxicity, by Region, Through 2023
  • Table 30: Global Market for HCS/I in Neuroscience, by Region, Through 2023
  • Table 31: Global Market for HCS/I in Compound Profiling, by Region, Through 2023
  • Table 32: North American Market for HCS/I, by Country, Through 2023
  • Table 33: North American Market for HCS/I, by Component, Through 2023
  • Table 34: North American Market for HCS/I, by End User, Through 2023
  • Table 35: North American Market for HCS/I, by Application, Through 2023
  • Table 36: Total Pharma Business R&D Expenditures in Canada, 2011-2015
  • Table 37: European Market for HCS/I, by Country, Through 2023
  • Table 38: European Market for HCS/I, by Component, Through 2023
  • Table 39: European Market for HCS/I, by End User, Through 2023
  • Table 40: European Market for HCS/I, by Application, Through 2023
  • Table 41: Asia-Pacific Market for HCS/I, by Country, Through 2023
  • Table 42: Asia-Pacific Market for HCS/I, by Component, Through 2023
  • Table 43: Asia-Pacific Market for HCS/I, by End User, Through 2023
  • Table 44: Asia-Pacific Market for HCS/I, by Application, Through 2023
  • Table 45: Vaccine Manufacturers in India
  • Table 46: ROW Market for HCS/I, by Component, Through 2023
  • Table 47: ROW Market for HCS/I, by End User, Through 2023
  • Table 48: ROW Market for HCS/I, by Application, Through 2023
  • Table 49: Number of Patents Issued, by Key Company/Assignee, January 2015, Through 2017
  • Table 50: Number of Patents Issued, by Category, 2015-2017
  • Table 51: Number of Patents Issued, by Country, 2015-2017
  • Table 52: Number of Patents Issued, by Publication Year, 2015-2017
  • Table 53: Patents Issued, January 2015-December 2017
  • Table 54: Thermo Fisher Scientific Products Covered One or More Patents
  • Table 55: GE Healthcare Patents, 2015-2017
  • Table 56: Molecular Devices Patents, 2015-2017
  • Table 57: Recent Collaborations in the HCS Market, January 2016-February 2018
  • Table 58: Recent Product Launches in the HCS Market, April 2015-March 2018
  • Table 59: Major Partnerships in the HCS Market, 2017
  • Table 60: Major Mergers and Acquisitions in the HCS Market, 2017

List of Figures

• Summary Figure: Global Market for High Content Screening/Imaging, by Component, 2017-2023
  • Figure 1: Approaches for Imaging Sample Surfaces
  • Figure 2: HCS in Drug Discovery
  • Figure 3: Four Steps of Data Analysis
  • Figure 4: Basic Tools for High Content Screening
  • Figure 5: Advantages of HTS
  • Figure 6: Application of High-Throughput Screening
  • Figure 7: Software Utilized for Data Analysis
  • Figure 8: Flow of Funding for Disease Research, 2014-2016
  • Figure 9: Investments, by Funding Category, 2016
  • Figure 10: Technological Advancements in HCS
  • Figure 11: Per Capita Healthcare Expenditures, 2016
  • Figure 12: GDP Growth Rate of India and China, 2013-2016
  • Figure 13: Key Benefits of Vectra Polaris Imaging Device
  • Figure 14: Five Main Components of a Flow Cytometer
  • Figure 15: Microplate Reader Categories
  • Figure 16: Features of ThiolTracker Violet
  • Figure 17: Features of HCS Studio 2.0 Cell Analysis Software
  • Figure 18: Features of Store Image and Database Management Software
  • Figure 19: Key Features of OpenHiCAMM
  • Figure 20: OpenHiCAMM: High Content Screening Software for Complex Microscope Imaging Workflows
  • Figure 21: Analysis of a Fluorescent Cellular Assay
  • Figure 22: Some of the Companies Contributing to Research and Drug Discovery
  • Figure 23: Incidence of Cancer in the U.S., 2017
  • Figure 24: Drug Discovery Cycle
  • Figure 25: Features of the Lead Compound
  • Figure 26: Timeline of Drug Discovery and Development
  • Figure 27: Types of Toxicity Studies
  • Figure 28: Percentage of New Cases by Age Group: Brain and Other Nervous System Cancers
  • Figure 29: Strategies to Improve Screening Using Compound Profiling
  • Figure 30: Gross Domestic Spending on R&D in North American Countries, 2016
  • Figure 31: U.S. Cancer Cases in Females, 2012
  • Figure 32: U.S. Cancer Cases in Males, 2012
  • Figure 33: Healthcare Expenditures for R&D, by U.S. State, 2016
  • Figure 34: Prevalence of Viral Hepatitis in the U.S., 2015
  • Figure 35: Gross Domestic Spending on Healthcare R&D in Canada, 2015 and 2016
  • Figure 36: Leading Causes of Death in Canada, 2017
  • Figure 37: Distribution of Projected Cancer Cases in Canada, by Type, 2017
  • Figure 38: European Union Investments in R&D Funding for Neglected Diseases, 2013-2016
  • Figure 39: Mortality from Cancer in the U.K., 2011-2017
  • Figure 40: U.K. Investments in R&D Funding for Neglected Diseases 2013-2016
  • Figure 41: Cancer Mortality in Germany, 2011-2017
  • Figure 42: Germany's Spending on Neglected Diseases, 2013-2016
  • Figure 43: Cancer Mortality in France, 2011-2017
  • Figure 44: Products in Development, by Therapeutic Application, 2016
  • Figure 45: French Spending on Neglected Diseases, 2013-2016
  • Figure 46: Cancer Mortality in Spain, 2011-2017
  • Figure 47: Spain's Spending on Neglected Diseases, 2013-2016
  • Figure 48: Cancer Mortality in Italy, 2011-2017
  • Figure 49: European Countries with High Cancer Mortality, 2014
  • Figure 50: Healthcare Expenditures in India
  • Figure 51: Healthcare Expenditures in China, 2016
  • Figure 52: Industry Structure of the High Content Screening Market
  • Figure 53: Strategies Adopted, by Key Market Players

Report Highlights:

The global market for high content screening/imaging should grow from $915.0 million in 2018 to reach $1.7 billion by 2023 at a compound annual growth rate (CAGR) of 13.1% for the period of 2018-2023.

Instrument or platform as a segment of high content screening/imaging should grow from $630.0 million in 2018 to reach $1.1 billion by 2023 at a CAGR of 12.2% for the period of 2018-2023.

Software and analytics as a segment of high content screening/imaging should grow from $70.0 million in 2018 to reach $151.0 million by 2023 at a CAGR of 16.6% for the period of 2018-2023.

Report Scope:

The HCS/I market has significant potential due to rising demand from the drug discovery and molecular diagnosis segments. The capabilities and possibilities of HCS/I market growth increases with the growth of new technologies and technological advancements. Emerging economies such as China, India, and South Korea are considered to be lucrative regions that are creating ample opportunities and scope for the market. Investments and funding from government and private ventures, research institutes and universities are supporting exploration into the potential of this market. Growing drug discovery and molecular diagnostic and research through HCS/I will further boost the market in the near future. The global rise in infectious and noninfectious diseases, growing populations, technological advancements and innovation are other factors creating considerable demand for HCS/I.

The scope of this study encompasses the current market for drug discovery, molecular diagnostics, cancer research, personalized medicine and compound profiling. The report also includes regulatory aspects, recent developments, market projections, competitive landscapes and market share. Analyses of patents, clinical trials, innovations and opportunities, as well as the latest trends, are also discussed in the report. The report intends to explain the key trends of HCS/I technologies and applications in various geographies. It also discusses the market determinants that act as motivating and restraining factors and provides insights to stakeholders and potential entrants. The report will be a key decision-making tool for government organizations, researchers, private players, angel investors, potential entrants and so forth.

Report Includes:

• 38 data tables and 23 additional tables

• An overview of the global markets for high content screening/imaging technologies

• Analyses of global market trends, with data from 2017, estimated from 2018 and projections of compound annual growth rates (CAGRs) through 2023

• Coverage of various microscope and imaging technologies in the industry

• Detailed analysis of the technological advancement in cytometers, light sources, detectors/sensors and liquid handling instruments

• Discussion of the various market motivators i.e. increasing R&D budget, advantages over manual and HTS, technological advancement, and automation

• Company profiles of major players in the industry, including Albany Molecular Research, Inc. (AMRI), Cell Signaling Technology, Danaher Corp., GE Healthcare and Instrument Systems

Table of Contents

Chapter 1: Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Intended Audience
• Scope of Report
• Information Sources
• Research Methodology
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

• Overview of Microscope and Imaging Technologies
  • Scanning Probe Microscopy
  • Scanning Electron Microscope
  • Transmission Electron Microscopy
• Technological Advancements
  • Cytometers
  • Detectors/Sensors
  • Liquid Handling Instruments
• Process Overview
  • High Content Screening
  • High Throughput Screening (HTS)
• Market Dynamics
  • Key Factors Driving the Market
  • Limitations and Challenges
  • Market Opportunities

Chapter 4: Market Breakdown by Component

• Instrument or Platform
  • Imaging Device
  • Cytometers
  • Plate Reader
  • Light Sources
  • Detectors/Sensors
  • Liquid Handling Instruments
• Consumables (Reagents and Kits)
• Software and Analytics
  • Store Image and Database Management Software by Thermo Fisher Scientific
  • OpenHiCAMM (Open Hi Content Acquisition for μManager) Software
• Services
  • siRNA Screens

Chapter 5: Market Breakdown by End User

• Academics
• Laboratories and Pathology Centers
• Companies (Biotechnology, Pharmaceutical and CRO)

Chapter 6: Market Breakdown by Application

• Molecular Diagnosis
• Oncology
• Drug Discovery
• Toxicity Studies
  • Acute Toxicity Studies
  • Subchronic Toxicity Studies
  • Chronic Toxicity
• Neuroscience
• Compound Profiling

Chapter 7: Market Breakdown by Region

• North America
  • United States
  • Canada
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
• MEA (Middle East and Africa)
• Asia-Pacific
  • India
  • China
  • Japan
  • Rest of Asia-Pacific
• Rest of the World

Chapter 8: Patent Review

Chapter 9: Industry Structure

• Manufacturers/Suppliers
  • Thermo Fisher Scientific
  • GE Healthcare
  • GE Healthcare Patents, 2015-2017
  • Olympus Corp.
  • Molecular Devices
  • PerkinElmer, Inc.

Chapter 10: Company Profiles

• ALBANY MOLECULAR RESEARCH, INC. (AMRI)
• AURELIA BIOSCIENCE LTD.
• AXXAM SPA
• BECTON, DICKINSON AND CO.
• BIOTEK INSTRUMENTS, INC.
• CHARLES RIVER
• CORNING, INC.
• CREATIVE BIOLABS
• CURIOX BIOSYSTEMS, INC.
• CYTOO SA
• DANAHER CORP.
• DE NOVO SOFTWARE
• DEFINIENS AG
• DISCOVERX CORP.
• ESSEN BIOSCIENCE
• EVOTEC AG
• FLUXION BIOSCIENCES
• GE HEALTHCARE
• GENEDATA AG
• HUDSON ROBOTICS, INC.
• INSTRUMENT SYSTEMS
• INTELLICYT CORP.
• LUMENCOR, INC.
• MERCK MILLIPORE
• MOLECULAR DEVICES
• NEMAMETRIX, INC.
• NIKON INSTRUMENTS, INC.
• OLYMPUS CORP.
• PERKINELMER, INC.
• PHENOVISTA BIOSCIENCES LLC
• PLATYPUS TECHNOLOGIES
• SYSMEX CORP.
• TECAN GROUP LTD.
• THERMO FISHER SCIENTIFIC, INC.
• THORLABS, INC.
• VALA SCIENCES, INC.
• YOKOGAWA ELECTRIC CORP.
• ZEISS GROUP